» Articles » PMID: 25991485

Parametric Response Mapping of Dynamic CT for Predicting Intrahepatic Recurrence of Hepatocellular Carcinoma After Conventional Transcatheter Arterial Chemoembolization

Overview
Journal Eur Radiol
Specialty Radiology
Date 2015 May 21
PMID 25991485
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aim of our study was to determine the diagnostic value of a novel image analysis method called parametric response mapping (PRM) for prediction of intrahepatic recurrence of hepatocellular carcinoma (HCC) treated with conventional transcatheter arterial chemoembolization (TACE).

Methods: This retrospective study was approved by the IRB. We recruited 55 HCC patients who achieved complete remission (CR) after TACE and received longitudinal multiphasic liver computed tomography (CT). The patients fell into two groups: the recurrent tumour group (n = 29) and the non-recurrent tumour group (n = 26). We applied the PRM analysis to see if this technique could distinguish between the two groups. The results of the PRM analysis were incorporated into a prediction algorithm. We retrospectively removed data from the last time point and attempted to predict the response to therapy of the removed data.

Results: The PRM analysis was able to distinguish between the non-recurrent and recurrent groups successfully. The prediction algorithm detected response to therapy with an area under the curve (AUC) of 0.76, while the manual approach had AUC 0.64.

Conclusions: Adopting PRM analysis can potentially distinguish between recurrent and non-recurrent HCCs and allow for prediction of response to therapy after TACE.

Key Points: Parametric response mapping (PRM) could help assess patients with recurrent HCCs after TACE. Parametric response mapping could direct patients to individualized therapy. Longitudinal CT images were analyzed with advanced image analysis method.

Citing Articles

Artificial Intelligence and Machine Learning Predicting Transarterial Chemoembolization Outcomes: A Systematic Review.

Cho E, Law M, Yu Z, Yong J, Tan C, Tan E Dig Dis Sci. 2024; 70(2):533-542.

PMID: 39708260 DOI: 10.1007/s10620-024-08747-5.


Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization.

Mendiratta-Lala M, Aslam A, Bai H, Chapiro J, De Baere T, Miyayama S Eur Radiol. 2023; 34(5):3284-3297.

PMID: 37930412 PMC: 11126446. DOI: 10.1007/s00330-023-10326-7.


Prognostic value of preoperative computed tomography in HBV-related hepatocellular carcinoma patients after curative resection.

Zhang W, Chen J, Liu L, Wang L, Liu J, Su D Onco Targets Ther. 2019; 12:3791-3804.

PMID: 31190879 PMC: 6529036. DOI: 10.2147/OTT.S199136.


[Research progress of CT/MRI parametric response map in precision evaluation of therapeutic response of cancer patients].

Zhang S, Chen F Zhejiang Da Xue Xue Bao Yi Xue Ban. 2018; 46(5):468-472.

PMID: 29488711 PMC: 10397068. DOI: 10.3785/j.issn.1008-9292.2017.10.03.


Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE.

Hinrichs J, Shin H, Kaercher D, Hasdemir D, Murray T, Kaireit T Eur Radiol. 2016; 26(10):3447-55.

PMID: 26769666 DOI: 10.1007/s00330-015-4203-4.


References
1.
Lai E, Fan S, Lo C, Chu K, Liu C, Wong J . Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg. 1995; 221(3):291-8. PMC: 1234572. DOI: 10.1097/00000658-199503000-00012. View

2.
Bruix J, Sherman M . Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53(3):1020-2. PMC: 3084991. DOI: 10.1002/hep.24199. View

3.
Meyer C, Boes J, Kim B, Bland P, Zasadny K, Kison P . Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal. 1997; 1(3):195-206. DOI: 10.1016/s1361-8415(97)85010-4. View

4.
Lee J, Chung Y, Song B, Shin J, Choi W, Yang S . Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol. 2002; 17(1):52-8. DOI: 10.1046/j.1440-1746.2002.02664.x. View

5.
Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L . Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology. 1995; 197(1):101-8. DOI: 10.1148/radiology.197.1.7568806. View